Skip to main content

Table 6 Survival sub-analysis at 40 months

From: Pirfenidone improves survival in IPF: results from a real-life study

  HR 95% CI P value
Centre 0.28 0.14,0.54 P < 0.0001
Gender 1.72 0.94,3.16 P < 0.077
Age 1.02 1.00,1.05 P < 0.033
FVC 0.97 0.96,0.98 P < 0.0001